AMPA receptor positive allosteric modulator
AMPA receptor positive allosteric modulator
An AMPA receptor positive allosteric modulator is a type of compound that enhances the activity of the AMPA receptor, a subtype of the ionotropic glutamate receptors in the central nervous system. These modulators bind to the receptor at a site distinct from the glutamate binding site, leading to an increase in the receptor's response to glutamate.
Mechanism of Action
AMPA receptor positive allosteric modulators work by binding to the allosteric site on the AMPA receptor. This binding induces a conformational change in the receptor, which increases its affinity for glutamate and/or prolongs the open state of the ion channel. As a result, there is an increase in the flow of sodium ions (Na_) and calcium ions (Ca__) into the neuron, leading to enhanced synaptic transmission and neuroplasticity.
Pharmacological Effects
The primary effect of AMPA receptor positive allosteric modulators is the potentiation of excitatory synaptic transmission. This can lead to improved cognitive function, enhanced memory, and increased alertness. These compounds are being investigated for their potential therapeutic effects in conditions such as Alzheimer's disease, schizophrenia, and depression.
Examples
Several compounds have been identified as AMPA receptor positive allosteric modulators, including:
- CX-516: Also known as Ampalex, CX-516 is one of the first AMPA receptor modulators to be studied for its cognitive-enhancing effects.
- Tulrampator: A more recent compound, Tulrampator has shown promise in preclinical studies for its potential to improve cognitive function.
Research and Development
Research into AMPA receptor positive allosteric modulators is ongoing, with a focus on developing compounds with improved efficacy and safety profiles. Challenges include minimizing potential side effects such as excitotoxicity and seizures, which can result from excessive activation of glutamate receptors.
Related pages
Gallery
AMPA_receptor_positive_allosteric_modulator
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD